Investments

Entvin AI Secures Y Combinator Funding to Expand Pharmaceutical Companies

The company, founded by Sanskar Jain, Hemant Phalak and Rishabh Arya, has developed an AI platform that streamlines the notoriously time-consuming, resource-intensive and complex FDA drug approval process, a market opportunity potentially worth billions as pharmaceutical companies worldwide seek to accelerate regulatory timelines and reduce compliance costs.